documents: EPA-HQ-OPP-2017-0489-0008

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
EPA-HQ-OPP-2017-0489-0008 EPA EPA-HQ-OPP-2017-0489 24-Epibrassinolide: Summary of Hazard and Science Policy Council (HASPOC) Meeting on July 12, 2018: Recommendations on the need for waivers for the following subchronic studies: 90-Day Dermal Study (OSCPP 870.3250) and 90-Day Inhalation Study (OCSPP 870.3465) Supporting & Related Material Memorandum 2019-06-19T04:00:00Z 2019 6     2019-06-20T00:37:18Z   0 0 0900006483ceec80

Links from other tables